Procainamide, a Drug Causing Lupus, Induces Prostaglandin H Synthase-2 and Formation of T Cell-Sensitizing Drug Metabolites in Mouse Macrophages
- 19 May 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 12 (6) , 488-500
- https://doi.org/10.1021/tx980001t
Abstract
Procainamide (PA) may cause drug-induced lupus, and its reactive metabolites, hydroxylamine-PA (HAPA) and nitroso-PA, are held responsible for this. Here, we show that N-oxidation of PA to these metabolites can take place in macrophages and lead to formation of neoantigens that sensitize T cells. Murine peritoneal macrophages (PMφ), exposed to PA in vitro, generated neoantigens related to HAPA as indicated by (1) their capacity to elicit a specific recall response of HAPA-primed T cells in the adoptive transfer popliteal lymph node (PLN) assay and (2) the appearance of metabolite-bound protein in PA-pulsed PMφ, as determined by Western blot. Analysis of five phase I enzymes that might be responsible for HAPA formation by PMφ pointed to prostaglandin H synthase-2 (PGHS-2) as a likely candidate. Experimental evidence that PA can be oxidized to HAPA by PGHS was obtained by exposing PA to PGHS in vitro. The resulting metabolites were identified by mass spectral analysis and covalent protein binding in ELISA. In vitro, PA exposure of PMφ of slow acetylator A/J and fast acetylator C57BL/6 mice failed to show significant strain differences in enzyme mRNA expression, enzyme activities, or formation of HAPA-related neoantigens. By contrast, after long-term PA treatment in vivo only in slow acetylators the PMφ harbored HAPA-related neoantigens and T cells were sensitized to them. PMφ of fast acetylator C57BL/6 mice only contained HAPA-related neoantigens, and their T cells were only sensitized to them if, in addition to long-term PA treatment, their donors had received injections of phorbol myristate acetate (PMA), a known enhancer of oxidative enzymes in phagocytes. In conclusion, PA treatment leads to N-oxidation of PA by enzymes, in particular PGHS-2, present in antigen-presenting cells (APC) and, hence, to generation of neoantigens which sensitize T cells. The enhanced neoantigen formation and T cell sensitization seen in slow acetylators might be explained by their higher concentration of PA substrate that is available for extrahepatic N-oxidation in APC.Keywords
This publication has 10 references indexed in Scilit:
- Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus.Journal of Clinical Investigation, 1997
- Predictive Immunotoxicological Test Systems: Suitability of the Popliteal Lymph Node Assay in Mice and RatsCritical Reviews in Toxicology, 1995
- Differentiation‐associated expression of prostaglandin G/H synthase in monocytic cellsFEBS Letters, 1993
- Preferential activation of Th2 cells in chronic graft-versus-host reaction.The Journal of Immunology, 1993
- The Role of Leukocyte-Generated Reactive Metabolites in the Pathogenesis of Ideosyncratic Drug ReactionsDrug Metabolism Reviews, 1992
- Prostaglandin H Synthase and Xenobiotic OxidationAnnual Review of Pharmacology and Toxicology, 1990
- The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases.Journal of Biological Chemistry, 1990
- Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro.Journal of Clinical Investigation, 1989
- Procainamide‐Induced Lupus Erythematosus‐like Syndrome in Relation to Acetylator Phenotype and Plasma Levels of ProcainamideActa Medica Scandinavica, 1979
- Effect of Acetylator Phenotype on the Rate at Which Procainamide Induces Antinuclear Antibodies and the Lupus SyndromeNew England Journal of Medicine, 1978